Beam Therapeutics Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Beam Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Beam Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $13.9M, a 28.3% decline year-over-year.
  • Beam Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $42.8M, a 48.5% decline year-over-year.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $45.3M, a 42.1% decline from 2022.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $78.3M, a 259% increase from 2021.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $21.8M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $45.3M -$33M -42.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $78.3M +$56.5M +259% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $21.8M +$83.7M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$61.8M -$58.7M -1849% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$3.17M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.